Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

398 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani S, Cuomo V, Piomelli D. Gaetani S, et al. Trends Mol Med. 2003 Nov;9(11):474-8. doi: 10.1016/j.molmed.2003.09.005. Trends Mol Med. 2003. PMID: 14604824
Formation and inactivation of endogenous cannabinoid anandamide in central neurons.
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. Di Marzo V, et al. Nature. 1994 Dec 15;372(6507):686-91. doi: 10.1038/372686a0. Nature. 1994. PMID: 7990962
Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.
Cadas H, Gaillet S, Beltramo M, Venance L, Piomelli D. Cadas H, et al. J Neurosci. 1996 Jun 15;16(12):3934-42. doi: 10.1523/JNEUROSCI.16-12-03934.1996. J Neurosci. 1996. PMID: 8656287 Free PMC article.
Anandamide (which activates cannabinoid CB1 receptors) and N-palmitoylethanolamine (which activates a CB2-like receptor subtype in mast cells) may both derive from cleavage of precursor phospholipid, N-acylphosphatidylethanolamine (NAPE), catalyzed by Ca(2+)-activated D-ty …
Anandamide (which activates cannabinoid CB1 receptors) and N-palmitoylethanolamine (which activates a CB2-like receptor subtype in mast cell …
A second endogenous cannabinoid that modulates long-term potentiation.
Stella N, Schweitzer P, Piomelli D. Stella N, et al. Nature. 1997 Aug 21;388(6644):773-8. doi: 10.1038/42015. Nature. 1997. PMID: 9285589
398 results
Jump to page
Feedback